Erlotinib

The Lancet Oncology: June 01, 2010

Listen to The Lancet Oncology

16 years ago

The Lancet Oncology: June 01, 2010

non-small-cell lung cancer

cancer

erlotinib

phase 3

maintenance

+5

+5

+4

+4

+3

+3

+2

+2

non-small-cell lung cancer

cancer

erlotinib

phase 3

maintenance

+5

+5

+4

+4

+3

+3

+2

+2

Journal of Clinical Oncology P

15 years ago

Biomarker Selection for Maintenance Therapy in Advanced NSCLC

erlotinib

biomarker

maintenancetherapy

advancednonsmallcelllungcancer

+4

+3

+3

+2

+2

+2

+1

+1

erlotinib

biomarker

maintenancetherapy

advancednonsmallcelllungcancer

+4

+3

+3

+2

+2

+2

+1

+1